Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReaGene Biosciences is an Indian private life sciences company focused on research reagents, translational assays, and human-relevant in vitro models for drug discovery. The company supplies reagents for cell culture, biochemistry, and molecular biology, and is developing alternatives to animal testing such as 3D live culture models, microfluidic systems, disease-in-a-dish models, and organ-on-a-chip-style approaches. Its named offerings include the ReaGene Discovery Platform, ReaSkin, ReaADME, ReaPath, ReaLite, and the ReaGEn translational 3D cell-based assay platform. ReaGene appears to operate primarily as a preclinical research tools and platform company rather than as a developer of a conventional therapeutic pipeline. The company is based in Bengaluru, India and has been described as founded and led by scientists with backgrounds in academia and the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReaGene Biosciences.